China Universal Asset Management Co., Ltd. Applied Therapeutics Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 23,339 shares of APLT stock, worth $8,402. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,339
Previous 24,672
5.4%
Holding current value
$8,402
Previous $20,000
45.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
94Shares Held
103MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$4.14 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.06 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$3.74 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$2.81 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.37 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $17.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...